A Study to Identify Microbiome Markers Associated with Preterm Labor

Overview

About this study

The purpose of this study is to identify components of the vaginal microbiology environment that contribute to the occurance of preterm labor and preterm delivery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Age ≥ 18
Ability to provide written informed consent
Willingness to participate in the mandatory translational research component of the study
Pregnant

Exclusion Criteria

Known immunodeficiency
Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C
Known autoimmune disease (e.g., rheumatoid arthritis or systemic lupus erythematosus)
Solid organ or transplant recipient
Multiple gestations
Oral or IV antibiotic treatment within the last 4 weeks
Known uterine anomalies
Evaluation following trauma event

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Margaret Dow, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Margaret Dow, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials